Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232163/
https://www.ncbi.nlm.nih.gov/pubmed/37266242
http://dx.doi.org/10.1155/2023/9832596
_version_ 1785051907616669696
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10232163
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-102321632023-06-01 Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-05-24 /pmc/articles/PMC10232163/ /pubmed/37266242 http://dx.doi.org/10.1155/2023/9832596 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
title Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
title_full Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
title_fullStr Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
title_full_unstemmed Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
title_short Retracted: Angiopep-2 as an Exogenous Chemical Exchange Saturation Transfer Contrast Agent in Diagnosis of Alzheimer's Disease
title_sort retracted: angiopep-2 as an exogenous chemical exchange saturation transfer contrast agent in diagnosis of alzheimer's disease
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232163/
https://www.ncbi.nlm.nih.gov/pubmed/37266242
http://dx.doi.org/10.1155/2023/9832596
work_keys_str_mv AT healthcareengineeringjournalof retractedangiopep2asanexogenouschemicalexchangesaturationtransfercontrastagentindiagnosisofalzheimersdisease

Ejemplares similares